A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice
2011

Humanin Reduces Amyloid Burden

Sample size: 34 publication 10 minutes Evidence: moderate

Author Information

Author(s): Niikura Takako, Sidahmed Elkhansa, Hirata-Fukae Chiho, Aisen Paul S., Matsuoka Yasuji

Primary Institution: Georgetown University

Hypothesis

Does the S14G-HN derivative of Humanin reduce amyloid beta accumulation and improve memory in triple transgenic mice?

Conclusion

S14G-HN treatment reduced amyloid beta levels and improved cognitive function in triple transgenic mice.

Supporting Evidence

  • S14G-HN treatment led to lower amyloid beta levels in the brains of treated mice compared to controls.
  • Behavioral tests indicated improved cognitive function in S14G-HN treated male mice.
  • Neprilysin levels were increased in the hippocampal region of S14G-HN treated mice.

Takeaway

A special protein called Humanin can help mice with Alzheimer's by lowering a harmful substance in their brains and helping them remember better.

Methodology

Triple transgenic mice were treated intranasally with S14G-HN for three months, followed by behavioral tests and analysis of amyloid beta levels.

Potential Biases

Potential bias due to the small sample size and gender differences in response to treatment.

Limitations

The study did not assess the long-term effects of S14G-HN treatment beyond the three-month period.

Participant Demographics

Male and female triple transgenic mice aged 13 months.

Statistical Information

P-Value

0.007

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016259

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication